CAS 1071517-39-9

Setrobuvir

Description:

Setrobuvir is an antiviral compound primarily investigated for its potential use in the treatment of hepatitis C virus (HCV) infections. As a member of the class of non-nucleoside inhibitors, it functions by targeting the viral polymerase, thereby disrupting the replication process of the virus. Setrobuvir exhibits a unique mechanism of action that differentiates it from traditional nucleoside analogs, making it a valuable candidate in combination therapies aimed at enhancing antiviral efficacy and reducing the likelihood of resistance development. The compound is characterized by its specific chemical structure, which includes various functional groups that contribute to its biological activity and solubility properties. In preclinical and clinical studies, Setrobuvir has shown promising results in terms of safety and tolerability, although further research is necessary to fully establish its therapeutic profile and optimal dosing regimens. As with many antiviral agents, ongoing investigations focus on its effectiveness in diverse patient populations and its potential role in combination with other antiviral therapies.

Formula: C₂₅H₂₅FN₄O₆S₂

InChI: InChI=1S/C25H25FN4O6S2/c1-37(33,34)28-17-8-9-18-19(11-17)38(35,36)29-24(27-18)21-23(31)20-14-4-5-15(10-14)22(20)30(25(21)32)12-13-2-6-16(26)7-3-13/h2-3,6-9,11,14-15,20,22,28,31H,4-5,10,12H2,1H3,(H,27,29)/t14-,15+,20+,22-/m0/s1

InChI key: InChIKey=DEKOYVOWOVJMPM-RLHIPHHXSA-N

SMILES: C(N1[C@@]2([C@@]([C@@]3(C[C@]2(CC3)[H])[H])(C(O)=C(C1=O)C=4NC=5C(S(=O)(=O)N4)=CC(NS(C)(=O)=O)=CC5)[H])[H])C6=CC=C(F)C=C6

Synonyms:

• Methanesulfonamide, N-[3-[(4aR,5S,8R,8aS)-1-[(4-fluorophenyl)methyl]-1,2,4a,5,6,7,8,8a-octahydro-4-hydroxy-2-oxo-5,8-methanoquinolin-3-yl]-1,1-dioxido-2H-1,2,4-benzothiadiazin-7-yl]-
• N-[3-[(4aR,5S,8R,8aS)-1-[(4-Fluorophenyl)methyl]-1,2,4a,5,6,7,8,8a-octahydro-4-hydroxy-2-oxo-5,8-methanoquinolin-3-yl]-1,1-dioxido-2H-1,2,4-benzothiadiazin-7-yl]methanesulfonamide
• Setrobuvir

Setrobuvir

CAS: 1071517-39-9

Setrobuvir

Purity: ≥98%

Molecular weight: 560.62g/mol

Ref: 54-BUP12248

Setrobuvir

Controlled Product

CAS: 1071517-39-9

Formula: C₂₅H₂₅FN₄O₆S₂

Color and Shape: Neat

Molecular weight: 560.618

Ref: TR-S101220

Setrobuvir (ana-598)

CAS: 1071517-39-9

Setrobuvir (ANA-598) is an investigational antiviral compound, which is a non-nucleoside inhibitor with specific activity against the Hepatitis C virus (HCV). It acts by targeting the NS5B polymerase, an enzyme essential for the replication of the viral RNA genome. By inhibiting this polymerase, Setrobuvir disrupts the viral life cycle, effectively preventing the virus from replicating within host cells.

Formula: C₂₅H₂₅FN₄O₆S₂

Purity: Min. 95%

Molecular weight: 560.6 g/mol

Ref: 3D-WSB51739

Setrobuvir

CAS: 1071517-39-9

Setrobuvir (ANA-598) is an orally active non-nucleoside HCV NS5B polymerase inhibitor with inhibitory effects on de novo RNA synthesis and primer extension with

Formula: C₂₅H₂₅FN₄O₆S₂

Purity: 98.92% - >99.99%

Color and Shape: Solid

Molecular weight: 560.62

Ref: TM-T28762